![Rita Jain](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rita Jain
Directeur/Membre du Conseil chez
SAB BIOTHERAPEUTICS, INC.
Fortune : 849 818 $ au 31/05/2026
Profil
Rita I.
Jain is currently an Independent Director at Avalo Therapeutics, Inc. since 2025, Celldex Therapeutics, Inc. since 2023, SAB Biotherapeutics, Inc. since 2026, and First Tracks Biotherapeutics, Inc. Former positions include Chief Medical Officer, Executive Director & EVP at ChemoCentryx, Inc. from 2021 to 2022; Director at Provention Bio, Inc. in 2023; Independent Director at AnaptysBio, Inc. from 2023 to 2026; Vice President-Pharmaceutical Development at Abbott Laboratories from 2003 to 2012; Vice President-Clinical Development at AbbVie, Inc. from 2013 to 2016; Chief Medical Officer & Senior Vice President at Akebia Therapeutics, Inc. from 2017 to 2019; Chief Medical Officer & Senior Vice President at Immunovant, Inc. in 2021; Member at North Shore University Hospital; Assistant Professor at New York University School of Medicine; Member-Supervisory Board at AM-Pharma Holding BV; and Member-Supervisory Board at AM-Pharma BV.
Education includes undergraduate studies at Long Island University and a doctorate from Stony Brook University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ANAPTYSBIO, INC. 0,04% | 06/01/2026 | 11 864 ( 0,04% ) | 660 469 $ | 31/05/2026 |
0,03% | 12/05/2026 | 11 864 ( 0,03% ) | 189 349 $ | 31/05/2026 |
| 10/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 02/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Rita Jain
| Sociétés | Poste | Début |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/02/2023 |
| AVALO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/06/2025 |
| SAB BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2026 |
Anciens postes connus de Rita Jain
| Sociétés | Poste | Fin |
|---|---|---|
| ANAPTYSBIO, INC. | Directeur/Membre du Conseil | 20/04/2026 |
| PROVENTION BIO, INC. | Directeur/Membre du Conseil | 27/04/2023 |
| CHEMOCENTRYX, INC. | Directeur Technique/Scientifique/R&D | 20/10/2022 |
| IMMUNOVANT, INC. | Directeur Technique/Scientifique/R&D | 01/06/2021 |
| AKEBIA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 17/06/2019 |
Formation de Rita Jain
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Long Island University
 Long Island University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AM-Pharma Holding BV
 AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Health Technology |
North Shore University Hospital
 North Shore University Hospital Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Celldex Therapeutics, Inc.
 Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stony Brook University School of Medicine
 Stony Brook University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
